Slide
Centre Interdisciplinaire
de Recherche et d’Innovation
en Cybersécurité et Société
de Recherche et d’Innovation
en Cybersécurité et Société
1.
Cousineau, H.; Marchand, A.; Bouchard, S.; Bélanger, C.; Gosselin, P.; Langlois, F.; Labrecque, J.; Dugas, M. J.; Belleville, G.
Insomnia symptoms following treatment for comorbid panic disorder with agoraphobia and generalized anxiety disorder Journal Article
In: Journal of Nervous and Mental Disease, vol. 204, no. 4, pp. 267–273, 2016, ISSN: 00223018, (Publisher: Lippincott Williams and Wilkins).
Abstract | Links | BibTeX | Tags: adult, agoraphobia, antidepressant agent, Anxiety Disorders, anxiolytic agent, article, clinical trial, cognitive therapy, cohort analysis, Cohort Studies, Combined Modality Therapy, comorbidity, comparative study, controlled study, Depression, disease severity, female, generalized anxiety disorder, human, Humans, hypnotic agent, insomnia, major clinical study, male, Middle Aged, multicenter study, multimodality cancer therapy, nocturnal panic attack, panic, Panic Disorder, panic disorder with agoraphobia, patient worry, procedures, psychoeducation, psychology, psychotropic agent, Psychotropic Drugs, quasi experimental study, Quebec, randomized controlled trial, Sleep Initiation and Maintenance Disorders, statistical significance, treatment outcome, wakefulness, Young Adult
@article{cousineau_insomnia_2016,
title = {Insomnia symptoms following treatment for comorbid panic disorder with agoraphobia and generalized anxiety disorder},
author = {H. Cousineau and A. Marchand and S. Bouchard and C. Bélanger and P. Gosselin and F. Langlois and J. Labrecque and M. J. Dugas and G. Belleville},
url = {https://www.scopus.com/inward/record.uri?eid=2-s2.0-84962128029&doi=10.1097%2fNMD.0000000000000466&partnerID=40&md5=2ca2dd82c29553bd7377ba64dd5522cc},
doi = {10.1097/NMD.0000000000000466},
issn = {00223018},
year = {2016},
date = {2016-01-01},
journal = {Journal of Nervous and Mental Disease},
volume = {204},
number = {4},
pages = {267–273},
abstract = {Patients with panic disorder with agoraphobia (PDA) or generalized anxiety disorder (GAD) frequently also suffer from insomnia. However, the impact of cognitive-behavioral therapy (CBT) for anxiety disorders on insomnia has been understudied. Furthermore, comorbidity between anxiety disorders is common. Our main objective was to assess the impact of CBT for PDA or GAD on insomnia. In a quasi-experimental design, 86 participants with PDA and GAD received conventional CBT for their primary disorder or combined CBT for both disorders. Overall, CBTs had a significant impact on reducing insomnia symptoms (η2 = 0.58). However, among people with insomnia at pretest (67%), 33% still had an insomnia diagnosis, and the majority (63%) had clinically significant residual insomnia following treatment. In conclusion, the CBTs had a positive effect on the reduction of insomnia, but a significant proportion of participants still had insomnia problems following treatment. Clinicians should address insomnia during CBT for PDA and GAD. Copyright © 2016 Wolters Kluwer Health, Inc. All rights reserved.},
note = {Publisher: Lippincott Williams and Wilkins},
keywords = {adult, agoraphobia, antidepressant agent, Anxiety Disorders, anxiolytic agent, article, clinical trial, cognitive therapy, cohort analysis, Cohort Studies, Combined Modality Therapy, comorbidity, comparative study, controlled study, Depression, disease severity, female, generalized anxiety disorder, human, Humans, hypnotic agent, insomnia, major clinical study, male, Middle Aged, multicenter study, multimodality cancer therapy, nocturnal panic attack, panic, Panic Disorder, panic disorder with agoraphobia, patient worry, procedures, psychoeducation, psychology, psychotropic agent, Psychotropic Drugs, quasi experimental study, Quebec, randomized controlled trial, Sleep Initiation and Maintenance Disorders, statistical significance, treatment outcome, wakefulness, Young Adult},
pubstate = {published},
tppubtype = {article}
}
Patients with panic disorder with agoraphobia (PDA) or generalized anxiety disorder (GAD) frequently also suffer from insomnia. However, the impact of cognitive-behavioral therapy (CBT) for anxiety disorders on insomnia has been understudied. Furthermore, comorbidity between anxiety disorders is common. Our main objective was to assess the impact of CBT for PDA or GAD on insomnia. In a quasi-experimental design, 86 participants with PDA and GAD received conventional CBT for their primary disorder or combined CBT for both disorders. Overall, CBTs had a significant impact on reducing insomnia symptoms (η2 = 0.58). However, among people with insomnia at pretest (67%), 33% still had an insomnia diagnosis, and the majority (63%) had clinically significant residual insomnia following treatment. In conclusion, the CBTs had a positive effect on the reduction of insomnia, but a significant proportion of participants still had insomnia problems following treatment. Clinicians should address insomnia during CBT for PDA and GAD. Copyright © 2016 Wolters Kluwer Health, Inc. All rights reserved.
2.
Roy, C.; Blais, C.; Fiset, D.; Rainville, P.; Gosselin, F.
Efficient information for recognizing pain in facial expressions Journal Article
In: European Journal of Pain (United Kingdom), vol. 19, no. 6, pp. 852–860, 2015, ISSN: 10903801 (ISSN).
Abstract | Links | BibTeX | Tags: anger, article, association, Classification, Cues, disgust, emotion, Emotions, Facial Expression, Fear, female, happiness, human, human experiment, Humans, male, nociception, normal human, Pain, pain assessment, Pattern Recognition, Photic Stimulation, photostimulation, physiology, priority journal, procedures, random sample, reproducibility, Reproducibility of Results, sadness, statistical significance, Visual, visual information, visual stimulation
@article{roy_efficient_2015,
title = {Efficient information for recognizing pain in facial expressions},
author = {C. Roy and C. Blais and D. Fiset and P. Rainville and F. Gosselin},
url = {https://www.scopus.com/inward/record.uri?eid=2-s2.0-84929122739&doi=10.1002%2fejp.676&partnerID=40&md5=027f6da7b6d5c98c86de6a07766fb83d},
doi = {10.1002/ejp.676},
issn = {10903801 (ISSN)},
year = {2015},
date = {2015-01-01},
journal = {European Journal of Pain (United Kingdom)},
volume = {19},
number = {6},
pages = {852–860},
abstract = {Background The face as a visual stimulus is a reliable source of information for judging the pain experienced by others. Until now, most studies investigating the facial expression of pain have used a descriptive method (i.e. Facial Action Coding System). However, the facial features that are relevant for the observer in the identification of the expression of pain remain largely unknown despite the strong medical impact that misjudging pain can have on patients' well-being. Methods Here, we investigated this question by applying the Bubbles method. Fifty healthy volunteers were asked to categorize facial expressions (the six basic emotions, pain and neutrality) displayed in stimuli obtained from a previously validated set and presented for 500 ms each. To determine the critical areas of the face used in this categorization task, the faces were partly masked based on random sampling of regions of the stimuli at different spatial frequency ranges. Results Results show that accurate pain discrimination relies mostly on the frown lines and the mouth. Finally, an ideal observer analysis indicated that the use of the frown lines in human observers could not be attributed to the objective 'informativeness' of this area. Conclusions Based on a recent study suggesting that this area codes for the affective dimension of pain, we propose that the visual system has evolved to focus primarily on the facial cues that signal the aversiveness of pain, consistent with the social role of facial expressions in the communication of potential threats. © 2015 European Pain Federation-EFIC®.},
keywords = {anger, article, association, Classification, Cues, disgust, emotion, Emotions, Facial Expression, Fear, female, happiness, human, human experiment, Humans, male, nociception, normal human, Pain, pain assessment, Pattern Recognition, Photic Stimulation, photostimulation, physiology, priority journal, procedures, random sample, reproducibility, Reproducibility of Results, sadness, statistical significance, Visual, visual information, visual stimulation},
pubstate = {published},
tppubtype = {article}
}
Background The face as a visual stimulus is a reliable source of information for judging the pain experienced by others. Until now, most studies investigating the facial expression of pain have used a descriptive method (i.e. Facial Action Coding System). However, the facial features that are relevant for the observer in the identification of the expression of pain remain largely unknown despite the strong medical impact that misjudging pain can have on patients' well-being. Methods Here, we investigated this question by applying the Bubbles method. Fifty healthy volunteers were asked to categorize facial expressions (the six basic emotions, pain and neutrality) displayed in stimuli obtained from a previously validated set and presented for 500 ms each. To determine the critical areas of the face used in this categorization task, the faces were partly masked based on random sampling of regions of the stimuli at different spatial frequency ranges. Results Results show that accurate pain discrimination relies mostly on the frown lines and the mouth. Finally, an ideal observer analysis indicated that the use of the frown lines in human observers could not be attributed to the objective 'informativeness' of this area. Conclusions Based on a recent study suggesting that this area codes for the affective dimension of pain, we propose that the visual system has evolved to focus primarily on the facial cues that signal the aversiveness of pain, consistent with the social role of facial expressions in the communication of potential threats. © 2015 European Pain Federation-EFIC®.